Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Oct. 31, 2017	Oct. 31, 2016	Oct. 31, 2017	Oct. 31, 2016
Income Statement [Abstract]
Sales-net of slotting fees and discounts	$ 7,351,355	$ 4,576,225	$ 19,714,090	$ 12,638,482
Costs of Sales	4,991,138	2,892,012	13,443,949	8,113,756
Gross profit	2,360,217	1,684,213	6,270,141	4,524,726
Operating expenses:
Research and development	27,528	38,529	77,647	106,316
General and administrative	1,914,914	1,402,121	5,251,090	4,339,234
Total operating expenses	1,942,442	1,440,650	5,328,737	4,445,550
Income from operations	417,775	243,563	941,404	79,176
Other income (expense):
Interest expense	(183,974)	(153,159)	(528,969)	(472,870)
Amortization of debt discount	(30,447)	(9,801)	(56,457)	(28,620)
Total other income (expense)	(214,421)	(162,960)	(585,426)	(501,490)
Net income (loss)	203,354	80,603	355,978	(422,314)
Less: preferred dividends		(46,800)	(91,565)	(158,121)
Net income (loss) available to common stockholders	$ 203,354	$ 33,803	$ 264,413	$ (580,435)
Net income (loss) per common share - basic	$ 0.01	$ 0.00	$ 0.01	$ (0.02)
Net income (loss) per common share - diluted	$ 0.01	$ 0.00	$ 0.01	$ (0.02)
Weighted average common shares outstanding – basic	31,503,665	27,257,834	29,152,736	26,937,969
Weighted average common shares outstanding – diluted	33,283,110	27,507,834	30,932,182	26,937,969